Nanocages (NCs) have emerged as a new class of drug-carriers, with a wide range of
possibilities in multi-modality medical treatments and theranostics. Nanocages can …

Diabetic nephropathy (DN) is the leading cause of end‐stage renal disease in many
countries. The animal models that recapitulate human DN undoubtedly facilitate our …

Diabetes increases the reabsorption of Na+ (TNa) and glucose via the sodium-glucose
cotransporter SGLT2 in the early proximal tubule (S1-S2 segments) of the renal cortex …

To date, imaging-guided multimodality therapy is important to improve the accuracy of the
diagnosis of renal fibrosis, and nanoplatforms for imaging-guided multimodality diagnosis …

A deficit or loss in the number of nephrons, the functional unit of the kidney, can induce
compensatory growth and hyperfunction of remaining nephrons. An increase in single …

Kidney disease affects more than 10% of the global population and is associated with
considerable morbidity and mortality, highlighting a need for new therapeutic options …

Nephron number (N glom) and size (Vglom) are correlated with risk for chronic
cardiovascular and kidney disease and may be predictive of renal allograft viability …

Biodegradable stents have tremendous theoretical potential as an alternative to bare metal
stents and drug-eluting stents for the treatment of obstructive coronary artery disease. Any …

Recent advances in medical imaging technology have greatly enhanced imaging-based
diagnosis which requires computational effective and accurate algorithms to process the …

Reduced nephron mass is strongly linked to susceptibility to chronic renal and
cardiovascular diseases. There are currently no tools to identify nephropenia in clinical or …